IP Library › Assignment 036130/0190
Patent Assignment
Reel/Frame 036130/0190

Merger

Recorded: 2015-07-18 Pages: 8
Assignor
OXFORD AMHERST CORPORATION
Executed: 2015-05-26
Assignee
PHARMACYCLICS, INC.
995 EAST ARQUES AVENUE, SUNNYVALE, CALIFORNIA, 94085
Covered Properties (71)
Texaphyrin Coordination Compounds and Uses Thereof
2-[5-(5-Carbaminidoyl-1H-Heteroaryl)-6-Hydroxybiphenyl-3-Yl]-Succinic Acid Derivatives as Factor as Factor Viia Inhibitors
Process for Affecting Neurologic Progression
Light Delivery Device Using Conical Diffusing System and Method of Forming Same
Preparation of Metallotexaphyrins
2-(2-Hydroxybiphenyl-3-Yl)-1H-Benzoimidazole-5-Carboxamidine Derivatives as Factor Viia Inhibitors
Sapphyrins and Uses Thereof
Novel Hydroxamates as Therapeutic Agents
Acetylene Derivatives as Inhibitors of Histone Deacetylase
Process for Inhibiting Cell Proliferation
Novel Hydroxamates as Therapeutic Agents
A Method of Enhancing Visualization of Atherosclerotic Lesions
Factor Viia Inhibitor
Factor Viia Inhibitor
High-Purity Texaphyrin Metal Complexes
Storage System for Texaphyrin Pharmaceutical Formulations
Method of Monitoring Anti-Tumor Activity of an Hdac Inhibitor
Motexafin Lutetium Photopherapy with Low Fluences for Treating Vascular Inflammation
Silanol Derivatives as Inhibitors of Histone Deacetylase
System and Method for Analysis of Neurological Condition
A Method for Treating Neurologic Diseases
Methods and Compositions for Treating Cancer
Inhibitors of Tyrosine Kinases and Uses Thereof
Inhibitors of Bruton's Tyrosine Kinase
Methods of Treating Cancer Using Hypofractionated Radiation and Texaphyrins
Indole Derivatives as Inhibitors of Histone Deacetylase
Water-Soluble Zinc Ionophores, Zinc Chelators, and/or Zinc Complexes and Use for Treating Cancer
Intracellular Kinase Inhibitors
Bruton's Tyrosine Kinase Activity Probe and Method of Using
Uses of Selective Inhibitors of HDAC8 for Treatment of T-Cell Proliferative Disorders
Uses of Selective Inhibitors of HDAC8 for Treatment of Inflammatory Conditions
Method of Using Histone Deacetylase Inhibitors and Monitoring Biomarkers in Combination Therapy
Method of Using Histone Deacetylase Inhibitors and Monitoring Biomarkers in Combination Therapy
Inhibitors of Bruton's Tyrosine Kinase
Calcium Flux as a Pharmacoefficacy Biomarker for Inhibitors of Histone Deacetylase
Manufacture, Formulations and Uses of Coagulation Factor Viia Modulator
Selective Inhibitors of Histone Deacetylase
Treatment of Non-Localized Inflammation with Pan-Hdac Inhibitors
Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors
Inhibitors of Bruton¿S Tyrosine Kinase
Formulations of Histone Deacetylase Inhibitor in Combination with Bendamustine and Uses Thereof
Methods and Compositions for Inhibition of Bone Resorption
Inhibitors of Bruton's Tyrosine Kinase
Use of Inhibitors of Bruton's Tyrosine Kinase (Btk)
Cinnamic Acid Hydroxyamides as Inhibitors of Histone Deacetylase 8
Pyrazolo [3, 4-D] Pyrimidine and Pyrrolo [2, 3-D] Pyrimidine Compounds as Kinase Inhibitors
Purinone Compounds as Kinase Inhibitors
Combinations of Histone Deacetylase Inhibitor and Pazopanib and Uses Thereof
Inhibitors of Bruton's Tyrosine Kinase
Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
Mutations Associated with Resistance to Inhibitors of Bruton's Tyrosine Kinase (Btk)
Companion Diagnostics for Tec Family Kinase Inhibitor Therapy
Pyrrolopyrimidine Compounds as Kinase Inhibitors
Inhibitors of Bruton's Tyrosine Kinase
Combinations of Bruton's Tyrosine Kinase Inhibitors and CYP3A4 Inhibitors
Ibrutinib Combination Therapy
Purinone Compounds as Kinase Inhibitors
Methods for the Treatment of Solid Tumors
Methods for the Treatment of HER2 Amplified Cancer
Inhibitors of Bruton's Tyrosine Kinase
Methods of Treating and Preventing Graft Versus Host Disease
Treatment Using Bruton's Tyrosine Kinase Inhibitors and Immunotherapy
Methods for Delaying or Preventing the Onset of Type 1 Diabetes
Methods of Treating and Preventing Alloantibody Driven Chronic Graft Versus Host Disease
Methods for Treating B Cell Proliferative Disorders
Inhibitors of Bruton's Tyrosine Kinase
Biomarkers for Predicting Response of Dlbcl to Treatment with Ibrutinib
Phospholipase C Gamma 2 and Resistance Associated Mutations
Hdac Inhibitor and Btk Inhibitor Combinations
Biomarker for Predicting Response of Cll to Treatment with a Btk Inhibitor
Btk Inhibitors for the Treatment of Cns Malignancies
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 26, 2005
From: CHEONG, WAI-FUNG; HEMMI, GREG; MADDEN, HUGO
To: PHARMACYCLICS, INC.
Reel/Frame 016687/0991 →
Assignment of Assignor's Interest Dec 5, 2005
From: VERNER, ERIK J.; SENDZIK, MARTIN; BASKARAN, CHITRA; BUGGY, JOSEPH J.
To: AXYS PHARMACEUTICALS INC
Reel/Frame 017090/0464 →
Assignment of Assignor's Interest May 3, 2007
From: MODY, TARAK D.; FU, LEI; CARY, DOUGLAS
To: PHARMACYCLICS, INC.
Reel/Frame 019245/0075 →
Assignment of Assignor's Interest Dec 3, 2007
From: DICKMAN, DANIEL A.; KUMAR, DANGE VIJAY; O'BRYAN, COLIN; RAI, ROOPA
To: AXYS PHARMACEUTICALS, INC.
Reel/Frame 020185/0730 →
Assignment of Assignor's Interest Dec 19, 2007
From: BAYS, ROLAND; MOSIMANN, LAURENT; WOODTLI, ALAIN; CHEONG, WAI-FUNG
To: PHARMACYCLICS, INC.
Reel/Frame 020267/0256 →
Assignment of Assignor's Interest Feb 8, 2008
From: AXYS PHARMACEUTICALS, INC.
To: PHARMACYCLICS, INC.
Reel/Frame 020505/0260 →
Assignment of Assignor's Interest Feb 15, 2008
From: AXYS PHARMACEUTICALS, INC.
To: PHARMACYCLICS, INC.
Reel/Frame 020513/0875 →
Assignment of Assignor's Interest May 6, 2008
From: BALASUBRAMANIAN, SRIRAM; BUGGY, JOSEPH J.; RAMOS, JASON; SIRISAWAD, MINT
To: PHARMACYCLICS, INC.
Reel/Frame 020904/0524 →
Confirmatory License Oct 5, 2009
From: UNIVERSITY OF TEXAS AUSTIN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023323/0391 →
Assignment of Assignor's Interest Jul 19, 2012
From: BUGGY, JOSEPH J.; CHANG, BETTY Y.
To: PHARMACYCLICS, INC.
Reel/Frame 028592/0651 →
Assignment of Assignor's Interest Jan 4, 2013
From: KLOOS, IOANA; DEPIL, STEPHANE
To: LES LABORATOIRES SERVIER SAS
Reel/Frame 029571/0450 →
Assignment of Assignor's Interest May 6, 2013
From: CHEN, WEI; LOURY, DAVID J.; MODY, TARAK D.; WANG, LONGCHENG
To: PHARMACYCLICS, INC.
Reel/Frame 030356/0409 →
Assignment of Assignor's Interest May 6, 2013
From: VERNER, ERIK; CHEN, WEI; BALASUBRAMANIAN, SRIRAM
To: PHARMACYCLICS, INC.
Reel/Frame 030356/0865 →
Assignment of Assignor's Interest May 7, 2013
From: CHEN, WEI; LOURY, DAVID J.
To: PHARMACYCLICS, INC.
Reel/Frame 030368/0336 →
Assignment of Assignor's Interest Jun 10, 2013
From: CHEN, WEI; LOURY, DAVID J.; MODY, TARAK D.
To: PHARMACYCLICS, INC.
Reel/Frame 030577/0022 →
Assignment of Assignor's Interest Jun 18, 2013
From: NANOSCALE COMBINATORIAL SYNTHESIS, INC. (NANOSYN)
To: PHARMACYCLICS, INC.
Reel/Frame 030635/0872 →
Assignment of Assignor's Interest Jun 18, 2013
From: PURRO, NORBERT
To: PHARMACYCLICS, INC.
Reel/Frame 030635/0621 →
Assignment of Assignor's Interest Jun 18, 2013
From: SMYTH, MARK; GOLDMAN, ERICK
To: PHARMACYCLICS, INC.
Reel/Frame 030635/0690 →
Assignment of Assignor's Interest Jun 18, 2013
From: WIRTH, DAVID D.
To: NANOSCALE COMBINATORIAL SYNTHESIS, INC. (NANOSYN)
Reel/Frame 030635/0813 →
Assignment of Assignor's Interest Feb 27, 2014
From: LOURY, DAVID J.; BUGGY, JOSEPH J.; MODY, TARAK D.; VERNER, ERIK J.
To: PHARMACYCLICS, INC.
Reel/Frame 032316/0704 →
Assignment of Assignor's Interest Feb 27, 2014
From: YAN, SHUNQI; WANG, LONGCHENG; FRYE, LEAH LYNN; CHEN, WEI
To: PHARMACYCLICS, INC.
Reel/Frame 032317/0446 →
Assignment of Assignor's Interest Feb 27, 2014
From: BALASUBRAMANIAN, SRIRAM; MODY, TARAK D.
To: PHARMACYCLICS, INC.
Reel/Frame 032317/0555 →
Assignment of Assignor's Interest Aug 4, 2014
From: MANNKIND CORPORATION
To: PHARMACYCLICS INC.
Reel/Frame 033454/0968 →
Assignment of Assignor's Interest Feb 18, 2015
From: KOLESNIKOV, ALEKSANDR; RAI, ROOPA; SHRADER, WILLIAM DVORAK; TORKELSON, STEVEN M.
To: AXYS PHARMACEUTICALS, INC.
Reel/Frame 035034/0437 →
Assignment of Assignor's Interest Feb 18, 2015
From: AXYS PHARMACEUTICALS, INC.
To: PHARMACYCLICS, INC.
Reel/Frame 035013/0571 →